LAURIE FENTON: Open Payments
NPI 1053687186 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,140 in 66 payments from 15 companies in 2025. Trend: 2023 $1,931 · 2024 $1,379 · 2025 $1,140
Food & beverage: $1,029Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $288 |
| Teva Pharmaceuticals USA, Inc. | 6 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $171 |
| Otsuka America Pharmaceutical, Inc. | 8 | $153 |
| Neurocrine BioSciences, Inc. | 4 | $86 |
| Novo Nordisk Inc | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Indivior Inc. | 1 | $25 |
| OWP Pharmaceuticals, Inc. | 1 | $25 |
Products named: VRAYLAR, CAPLYTA, REXULTI, INGREZZA, UZEDY, ABILIFY ASIMTUFII, Jornay PM, Wegovy.
Industry payments across NY — which companies pay providers there.
